Trexquant Investment’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-77,350
Closed -$4.97M 2270
2026
Q1
$4.97M Buy
77,350
+15,156
+24% +$1.38M 0.04% 649
2025
Q4
$8.09M Buy
62,194
+27,720
+80% +$3.8M 0.07% 386
2025
Q3
$3.71M Buy
+34,474
New +$3.76M 0.04% 659
2025
Q1
Sell
-74,912
Closed -$5.76M 1907
2024
Q4
$5.76M Sell
74,912
-47,100
-39% -$3.29M 0.07% 474
2024
Q3
$5.18M Buy
122,012
+59,226
+94% +$2M 0.07% 460
2024
Q2
$1.64M Buy
+62,786
New +$1.19M 0.03% 819
2023
Q4
Sell
-45,532
Closed -$166K 1841
2023
Q3
$166K Buy
45,532
+15,986
+54% +$87.6K ﹤0.01% 1361
2023
Q2
$176K Buy
+29,546
New +$234K ﹤0.01% 1337
2022
Q1
Sell
-369
Closed -$54K 1772
2021
Q4
$54K Buy
+369
New +$82.4K ﹤0.01% 1249

Other funds holding WGS

Trexquant Investment's WGS Position: Q2 2026 in Review

Trexquant Investment sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 77,350 shares — an estimated $4.97M sold.

Trexquant Investment first reported a position in WGS in Q4 2021 and held it in 9 quarters. The position peaked at $8.09M in Q4 2025. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Trexquant Investment reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 77,350 GeneDx Holdings shares in Q2 2026, an estimated $4.97M.
  • Trexquant Investment first reported a position in GeneDx Holdings in Q4 2021 and held it in 9 quarters.
  • Trexquant Investment's GeneDx Holdings position peaked at $8.09M in Q4 2025.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.